Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liu Ping

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Journal of Global Health|September 20, 2024
Prevalence and disparities in sexual and reproductive health of women of reproductive age (20-49 years) in China: A national cross-sectional studyTian Tian, Rui Yang, Yu Fu, et al.
Hepatology International|June 29, 2023
Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patientsKong-Ying Lin, Zhi-Wen Lin, Qing-Jing Chen, et al.
Cancer Management and Research|June 27, 2019
Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinomaMeng-Xin Tian, Liu-Ping Luo, Wei-Ren Liu, et al.
Frontiers in Immunology|March 4, 2024
Serum alpha-fetoprotein response as a preoperative prognostic indicator in unresectable hepatocellular carcinoma with salvage hepatectomy following conversion therapy: a multicenter retrospective studyKong-Ying Lin, Jian-Xi Zhang, Zhi-Wen Lin, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|April 5, 2025
Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence: A multicenter prospective cohort studyJin-Hong Chen, Lu Lu, Xiao-Yun Zhang, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Journal of Global Health|September 20, 2024
Prevalence and disparities in sexual and reproductive health of women of reproductive age (20-49 years) in China: A national cross-sectional studyTian Tian, Rui Yang, Yu Fu, et al.
Hepatology International|June 29, 2023
Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patientsKong-Ying Lin, Zhi-Wen Lin, Qing-Jing Chen, et al.
Cancer Management and Research|June 27, 2019
Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinomaMeng-Xin Tian, Liu-Ping Luo, Wei-Ren Liu, et al.
Frontiers in Immunology|March 4, 2024
Serum alpha-fetoprotein response as a preoperative prognostic indicator in unresectable hepatocellular carcinoma with salvage hepatectomy following conversion therapy: a multicenter retrospective studyKong-Ying Lin, Jian-Xi Zhang, Zhi-Wen Lin, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|April 5, 2025
Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence: A multicenter prospective cohort studyJin-Hong Chen, Lu Lu, Xiao-Yun Zhang, et al.
Pageof 9